William Domarad, DO
Neurology · Vancouver, WANPI 1831108455
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations.
Across 86 payments — averaging $21.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$220
- UCB, Inc.$218
- EMD Serono, Inc.$211
- Amgen$171
- AstraZeneca$164
- Collegium Pharmaceutical, Inc.$106
- plus $799 from 26 others
What the payments were for
- Food & beverage$1,889100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 12 | $220 |
| UCB, Inc. | 11 | $218 |
| EMD Serono, Inc. | 3 | $211 |
| Amgen | 5 | $171 |
| AstraZeneca(2 entities) | 6 | $164 |
| Collegium Pharmaceutical, Inc. | 6 | $106 |
| AbbVie(2 entities) | 3 | $61 |
| Sanofi | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Genentech USA, Inc. | 2 | $46 |
| Novartis | 3 | $45 |
| Kyowa Kirin, Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Lundbeck LLC | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Eisai Inc. | 2 | $35 |
| Johnson & Johnson | 1 | $31 |
| Harmony Biosciences LLC | 1 | $31 |
| Lilly USA, LLC | 2 | $28 |
| Acadia Pharmaceuticals Inc | 2 | $27 |
| CSL Behring | 1 | $27 |
| Banner Life Sciences, LLC | 1 | $24 |
| Argenx US, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $19 |
| SK Life Science, Inc. | 1 | $19 |
| Neurelis, Inc. | 1 | $18 |
| Boston Scientific | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Catalyst Pharmaceuticals, Inc. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Bristol Myers Squibb | 1 | $12 |
How this compares
$1,889 in reported general payments places this provider in the 75th percentile of 418 neurology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 36 | $1,216 |
| Donepezil Hcl | 124 | $902 |
| Memantine Hcl | 47 | $689 |
| Divalproex Sodium ErDivalproex Sodium | 18 | $655 |
| Levetiracetam | 20 | $483 |
| Duloxetine Hcl | 29 | $437 |
| Gabapentin | 33 | $363 |
| Primidone | 28 | $284 |
| Benztropine Mesylate | 13 | $268 |
| Propranolol Hcl | 11 | $173 |
| Lamotrigine | 14 | $146 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 19 | $79 |
| Sertraline Hcl | 32 | $62 |
Paid to pharmacies, not to this prescriber.
Other neurology in Vancouver
- Gurjeet SinghVancouver$60K
- John DempsterVancouver$43K
- Pavle RepovicSeattle$1.1M
- Jason AldredSpokane$1M
- Pinky AgarwalKirkland$795K
- Stacy DonlonTacoma$613K
- Nathaniel WatsonSeattle$486K
- James BowenKirkland$379K
- Christyn EdmundsonSeattle$318K
- Jessica CraddockSpokane$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.